Xofigo® - radium Ra 223 dichloride injection

Important Safety Information

Do not take Xofigo if you are pregnant or may become pregnant. Xofigo can harm your unborn baby. Women who are pregnant or
who may become pregnant should not come in contact with Xofigo without protection, such as gloves. Continue reading below

Supporting Your Journey

While you should always talk to your doctor,
these resources may be helpful.

Xofigo® Private
Commercially Insured
Patient Assistance

Xofigo Access Services provides a variety of programs to support you, including:

  • $0 Copay assistance
  • Financial and reimbursement
  • Prior authorization
  • Support for you and your caregivers

*Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, e.g., co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payors of any benefits they receive and the value of this program, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Patients enrolled in Bayer’s Patient Assistance Program are not eligible. Bayer may determine eligibility, monitor participation, equitably distribute product and modify or discontinue any aspect of the Xofigo Access Services at any time, including but not limited to this commercial co-pay assistance program. Only patients not currently enrolled in the Xofigo Access Services are eligible; current participants may enroll upon their annual renewal date.

Indication

Xofigo® (radium Ra 223 dichloride) injection is used to treat prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to your bones with symptoms, but not to other parts of your body. The medical term for this condition is metastatic castration-resistant prostate cancer, or mCRPC.

Important Safety Information

Do not take Xofigo if you are pregnant or may become pregnant. Xofigo can harm your unborn baby. Women who are pregnant or who may become pregnant should not come in contact with Xofigo without protection, such as gloves.

Before taking Xofigo, tell your healthcare provider if you:

While you are on Xofigo:

The most common side effects of Xofigo include:

Tell your healthcare provider if you have any side effects that bother you or do not go away.

You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call
1-800-FDA-1088. For important risk and use information about Xofigo, please see the Full Prescribing Information.